The relative value of conventional staging procedures for developing prognostic models in extensive-stage small-cell lung cancer

Richard G. Sheehan, Edward Balaban, John V. Cox, Eugene P. Frenkel

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Published prognostic models for small-cell lung cancer (SCLC) have either combined limited- and extensive-stage patients or have not included standard anatomic staging information to assess the relative value of the knowledge of specific sites and number of sites of metastases in predicting survival in extensive-stage disease. We studied 136 extensive-stage patients in whom traditional staging procedures were performed and in whom other previously demonstrated significant pretreatment variables were determined. Using the Cox proportional hazards model, when all data were included, three variables were significantperformance status (PS) (P= .0001), number of sites of metastases (P = .0010), and age (P = .0029). A prognostic algorithm was developed using these variables, which divided the patients into three distinct groups. When the anatomic staging data were omitted, the serum albumin (P = .0313) was the only variable in addition to PS (P = .0001) and age (P = .0064) that was significant. An alternative algorithm using these three variables was nearly as predictive as the original. Therefore, in extensive-stage patients, reasonable pretreatment prognostic information can be obtained without using the number or specific sites of metastases as variables once the presence of distant metastases has been demonstrated.

Original languageEnglish (US)
Pages (from-to)2047-2053
Number of pages7
JournalJournal of Clinical Oncology
Volume8
Issue number12
DOIs
StatePublished - Jan 1 1990

Fingerprint

Small Cell Lung Carcinoma
Neoplasm Metastasis
Proportional Hazards Models
Serum Albumin
Survival

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

@article{42b2194d763a4dcebd8832f70d4eed63,
title = "The relative value of conventional staging procedures for developing prognostic models in extensive-stage small-cell lung cancer",
abstract = "Published prognostic models for small-cell lung cancer (SCLC) have either combined limited- and extensive-stage patients or have not included standard anatomic staging information to assess the relative value of the knowledge of specific sites and number of sites of metastases in predicting survival in extensive-stage disease. We studied 136 extensive-stage patients in whom traditional staging procedures were performed and in whom other previously demonstrated significant pretreatment variables were determined. Using the Cox proportional hazards model, when all data were included, three variables were significantperformance status (PS) (P= .0001), number of sites of metastases (P = .0010), and age (P = .0029). A prognostic algorithm was developed using these variables, which divided the patients into three distinct groups. When the anatomic staging data were omitted, the serum albumin (P = .0313) was the only variable in addition to PS (P = .0001) and age (P = .0064) that was significant. An alternative algorithm using these three variables was nearly as predictive as the original. Therefore, in extensive-stage patients, reasonable pretreatment prognostic information can be obtained without using the number or specific sites of metastases as variables once the presence of distant metastases has been demonstrated.",
author = "Sheehan, {Richard G.} and Edward Balaban and Cox, {John V.} and Frenkel, {Eugene P.}",
year = "1990",
month = "1",
day = "1",
doi = "10.1200/JCO.1990.8.12.2047",
language = "English (US)",
volume = "8",
pages = "2047--2053",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "12",

}

The relative value of conventional staging procedures for developing prognostic models in extensive-stage small-cell lung cancer. / Sheehan, Richard G.; Balaban, Edward; Cox, John V.; Frenkel, Eugene P.

In: Journal of Clinical Oncology, Vol. 8, No. 12, 01.01.1990, p. 2047-2053.

Research output: Contribution to journalArticle

TY - JOUR

T1 - The relative value of conventional staging procedures for developing prognostic models in extensive-stage small-cell lung cancer

AU - Sheehan, Richard G.

AU - Balaban, Edward

AU - Cox, John V.

AU - Frenkel, Eugene P.

PY - 1990/1/1

Y1 - 1990/1/1

N2 - Published prognostic models for small-cell lung cancer (SCLC) have either combined limited- and extensive-stage patients or have not included standard anatomic staging information to assess the relative value of the knowledge of specific sites and number of sites of metastases in predicting survival in extensive-stage disease. We studied 136 extensive-stage patients in whom traditional staging procedures were performed and in whom other previously demonstrated significant pretreatment variables were determined. Using the Cox proportional hazards model, when all data were included, three variables were significantperformance status (PS) (P= .0001), number of sites of metastases (P = .0010), and age (P = .0029). A prognostic algorithm was developed using these variables, which divided the patients into three distinct groups. When the anatomic staging data were omitted, the serum albumin (P = .0313) was the only variable in addition to PS (P = .0001) and age (P = .0064) that was significant. An alternative algorithm using these three variables was nearly as predictive as the original. Therefore, in extensive-stage patients, reasonable pretreatment prognostic information can be obtained without using the number or specific sites of metastases as variables once the presence of distant metastases has been demonstrated.

AB - Published prognostic models for small-cell lung cancer (SCLC) have either combined limited- and extensive-stage patients or have not included standard anatomic staging information to assess the relative value of the knowledge of specific sites and number of sites of metastases in predicting survival in extensive-stage disease. We studied 136 extensive-stage patients in whom traditional staging procedures were performed and in whom other previously demonstrated significant pretreatment variables were determined. Using the Cox proportional hazards model, when all data were included, three variables were significantperformance status (PS) (P= .0001), number of sites of metastases (P = .0010), and age (P = .0029). A prognostic algorithm was developed using these variables, which divided the patients into three distinct groups. When the anatomic staging data were omitted, the serum albumin (P = .0313) was the only variable in addition to PS (P = .0001) and age (P = .0064) that was significant. An alternative algorithm using these three variables was nearly as predictive as the original. Therefore, in extensive-stage patients, reasonable pretreatment prognostic information can be obtained without using the number or specific sites of metastases as variables once the presence of distant metastases has been demonstrated.

UR - http://www.scopus.com/inward/record.url?scp=0025678639&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025678639&partnerID=8YFLogxK

U2 - 10.1200/JCO.1990.8.12.2047

DO - 10.1200/JCO.1990.8.12.2047

M3 - Article

VL - 8

SP - 2047

EP - 2053

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 12

ER -